SynAct Q4 2024: Successful Rights Issue Funds 2025 - Redeye

Redeye comments on Synact's Q4 report. Synact raised in total SEK65m from a combined rights and directed share issue in December-January. This will fund 2025 and the recruitment of 240 patients in the phase IIb study Advance.

Länk till analysen i sin helhet: https://www.redeye.se/research/1079389/synact-q4-2024-successful-rights-issue-funds-2025?utm_source=finwire&utm_medium=RSS